Until 1932, investigators of diseases of the pancreas used the concentration of that fat-splitting enzyme in the serum which is capable of splitting simple esters (esterase) in the diagnosis of pancreatic disease; but the results were too variable to be of great value. In 1932, Cherry and Crandall1 reexamined the problem of fat-splitting enzymes in the serum, finding that the activity of the esterase as measured by hydrolysis of ethyl butyrate or tributyrin was affected in one of three ways: it was increased, decreased, or was not changed following experimental ligation of the pancreatic duct of dogs. They therefore concluded
Learn more about subscription options.
Register Now for a free account.
SERUM LIPASE IN THE DIAGNOSIS OF THE DISEASES OF THE PANCREAS. Ann Intern Med. 1939;12:1896-1899. doi: 10.7326/0003-4819-12-11-1896
Download citation file:
Published: Ann Intern Med. 1939;12(11):1896-1899.
Gastroenterology/Hepatology, Pancreatic Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only